Skip to main content
Log in

NosocomialCryptococcus laurentii fungemia in a bone marrow transplant patient after prophylaxis with ketoconazole successfully treated with oral fluconazole

  • Correspondence
  • Published:
Infection Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Annaisie, E., Bodey, G. New emerging fungal pathogens. Eur. J. Clin. Microbiol. Inf. Dis. 11 (1992) 339–342.

    Google Scholar 

  2. Krčméry, V. Jr. Candidiasis, apergillosis and mucormycosis in cancer centre. Mycoses 10 (1991) 321–323.

    Google Scholar 

  3. Goodman, J. andthe BMT study group A prospective randomised trial in fluconazole versus placebo for prevention of fungal infections in BMT patients. N. Engl. J. Med. 326 (1992) 1192–1199.

    PubMed  Google Scholar 

  4. Kunova, A., Krčméry, V. Jr. C. glabrata, C. krusei and other non-albicansCandida spp. surveillance in 5 years in National Cancer Centre. Chemotherapy 41 (1995) 44–49.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krčméry, V., Kunova, A. & Mardiak, J. NosocomialCryptococcus laurentii fungemia in a bone marrow transplant patient after prophylaxis with ketoconazole successfully treated with oral fluconazole. Infection 25, 130 (1997). https://doi.org/10.1007/BF02113596

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02113596

Keywords

Navigation